1. Home
  2. SION vs XNET Comparison

SION vs XNET Comparison

Compare SION & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • XNET
  • Stock Information
  • Founded
  • SION 2019
  • XNET 2003
  • Country
  • SION United States
  • XNET China
  • Employees
  • SION N/A
  • XNET N/A
  • Industry
  • SION
  • XNET Computer Software: Prepackaged Software
  • Sector
  • SION
  • XNET Technology
  • Exchange
  • SION NYSE
  • XNET Nasdaq
  • Market Cap
  • SION 338.0M
  • XNET 276.3M
  • IPO Year
  • SION 2025
  • XNET 2014
  • Fundamental
  • Price
  • SION $12.57
  • XNET $4.50
  • Analyst Decision
  • SION Strong Buy
  • XNET
  • Analyst Count
  • SION 1
  • XNET 0
  • Target Price
  • SION $32.00
  • XNET N/A
  • AVG Volume (30 Days)
  • SION 128.6K
  • XNET 384.1K
  • Earning Date
  • SION 05-25-2025
  • XNET 05-15-2025
  • Dividend Yield
  • SION N/A
  • XNET N/A
  • EPS Growth
  • SION N/A
  • XNET N/A
  • EPS
  • SION N/A
  • XNET 0.02
  • Revenue
  • SION N/A
  • XNET $323,140,000.00
  • Revenue This Year
  • SION N/A
  • XNET N/A
  • Revenue Next Year
  • SION N/A
  • XNET N/A
  • P/E Ratio
  • SION N/A
  • XNET $226.84
  • Revenue Growth
  • SION N/A
  • XNET N/A
  • 52 Week Low
  • SION $7.26
  • XNET $1.46
  • 52 Week High
  • SION $25.19
  • XNET $5.52
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • XNET 58.25
  • Support Level
  • SION N/A
  • XNET $4.25
  • Resistance Level
  • SION N/A
  • XNET $4.54
  • Average True Range (ATR)
  • SION 0.00
  • XNET 0.22
  • MACD
  • SION 0.00
  • XNET 0.07
  • Stochastic Oscillator
  • SION 0.00
  • XNET 81.82

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

Share on Social Networks: